Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
However, none are yet approved by the EMA or FDA specifically for the treatment of obesity, though trials in obese people without T2D have shown promising results [61]
How to Get Retatrutide With a Clinical Trial Retatrutide phase 3 trials are winding up in 2026 with trial results that will lead to the anticipated FDA approval by summer 2026
Both medications require regular monitoring of blood glucose levels for effective diabetes management
Accessed January 12, 2025
US$ 22.61
US$ 27.91
US$ 25.76
US$ 20.72
US$ 21.58
US$ 29.87
US$ 29.87
US$ 20.81
US$ 26.95
